Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2736105 | 0.78 | KMT2A (0.40) | KMT2AALDH1A1SMN1; SMN2HTT | |
| SCHEMBL19996824 | 0.70 | KMT2A (0.39) | KMT2AALDH1A1SMN1; SMN2HTT | |
| SCHEMBL1300241 | 0.70 | GRIA1 (0.39) | KMT2AALDH1A1SMN1; SMN2HTT | |
| SCHEMBL18198023 | 0.70 | GRIA1 (0.62) | KMT2AALDH1A1SMN1; SMN2HTT | |
| SCHEMBL966015 | 0.70 | CA1 (0.50) | KMT2AALDH1A1SMN1; SMN2HTT | |
| SCHEMBL2581603 | 0.69 | KMT2A (0.41) | KMT2AALDH1A1SMN1; SMN2HTT | |
| SCHEMBL19996825 | 0.69 | GRIA1 (0.43) | KMT2AALDH1A1SMN1; SMN2HTT | |
| SCHEMBL3204936 | 0.68 | CA12 (0.40) | KMT2AALDH1A1SMN1; SMN2HTT | |
| SCHEMBL40975 | 0.67 | LMNA (0.35) | KMT2AALDH1A1SMN1; SMN2HTT | |
| SCHEMBL12384308 | 0.66 | CA1 (0.36) | KMT2AALDH1A1SMN1; SMN2HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3321279-B1 | EXENATIDE MODIFIER AND USE THEREOF | BRIGHTGENE BIO MEDICAL TECH CO LTD (CN) | 2020-02-12 | — | — | EP | disclosed |